Back to search

Article

EvoSynth: Enabling Multi-Target Drug Discovery through Latent Evolutionary Optimization and Synthesis-Aware Prioritization

2025-11-05

Abstract excerpt

<h4>ABSTRACT</h4> Complex diseases, such as cancer and neurodegeneration, feature interconnected pathways, making single-target therapies ineffective due to pathway redundancy and compensatory mechanisms. Polypharmacy, which combines multiple drugs to target distinct proteins, addresses this but often leads to drug-drug interactions, cumulative toxicity, and complex pharmacokinetics. To overcome these challenges,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e85d602-011b-5301-b56c-4a459c08a465
DOI
10.1101/2025.11.04.686584
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EvoSynth: Enabling Multi-Target Drug Discovery through Latent Evolutionary Optimization and Synthesis-Aware PrioritizationDOI 10.1101/2025.11.04.686584
Select a neighboring publication to make it the new centre.